Analysis of liver enzyme damage indicated a trend toward a reduction of plasma ALT in CCl 4 -treated EphB2−/ − mice compared to CCl 4 -treated EphB2 +/+ mice although this trend did not reach statistical significance (Fig. 5h ).
← all excerpts
EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells.
1
—
—